Wenli Cheng

机构：Capital Medical University, Anhui Medical University, Beijing Anzhen Hospital · ORCID：0000-0002-4820-3531

发表论文 55 篇 · 总被引 658 次 · h-index 15

代表论文

• New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC (2022 · Frontiers in Pharmacology · 被引 47)
• Close association of PFASs exposure with hepatic fibrosis than steatosis: evidences from NHANES 2017–2018 (2023 · Annals of Medicine · 被引 36)
• Phytochemicals derived from Nicotiana tabacum L. plant contribute to pharmaceutical development (2024 · Frontiers in Pharmacology · 被引 30)
• New aspects characterizing non-obese NAFLD by the analysis of the intestinal flora and metabolites using a mouse model (2024 · mSystems · 被引 20)
• Effect of theaflavin-3,3′-digallate on leptin-deficient induced nonalcoholic fatty liver disease might be related to lipid metabolism regulated by the Fads1/PPARδ/Fabp4 axis and gut microbiota (2022 · Frontiers in Pharmacology · 被引 17)
• Geniposide reduced oxidative stress-induced apoptosis in HK-2 cell through PI3K/AKT3/FOXO1 by m6A modification (2024 · International Immunopharmacology · 被引 15)